Live Breaking News & Updates on Caris Molecular Intelligence|Page 5

Share this article
Share this article
IRVING, Texas, Feb. 16, 2021 /PRNewswire/  Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced today that the Dana-Farber Cancer Institute (Dana-Farber) has joined Caris Precision Oncology Alliance™ (The Alliance/POA). The Alliance is a collaborative network of leading cancer centers that work together to advance comprehensive cancer profiling and establish standards for molecular testing in oncology through research focused on predictive and prognostic markers that improve the clinical outcomes of patients with cancer. At Dana-Farber, it will operate out of the Lank Center for Genitourinary Oncology. ....

New York , United States , Dana Farber Cancer Institute , Chadi Nabhan , Brianj Brille , Lindsey Bailys , Caris Codeai , Dana Farber Brigham , Himisha Beltran , Caris Pharmatech , Time Clinical Trial Solutions , Caris Life Sciences Media Contact , Women Cancer Center , National Cancer Comprehensive Center , Cari Precision Oncology Alliance , Oncology Network , National Comprehensive Cancer Network , Caris Precision Oncology Alliance , Blood Disorders Center , Harvard Medical School , Lank Center , Dana Farber Cancer Institute Media Contact , Precision Oncology Alliance , Dana Farber Harvard Cancer Center , Caris Life Sciences , Boston Children ,